{"abstract": "The agency declined to approve a medication called denosumab, meant to treat osteoporosis, until it has more data.", "web_url": "https://www.nytimes.com/2009/10/20/business/20amgen.html", "snippet": "The agency declined to approve a medication called denosumab, meant to treat osteoporosis, until it has more data.", "lead_paragraph": "Amgen has failed to win approval from the Food and Drug Administration, for now at least, for the bone-strengthening drug that the company has been counting on to propel its growth.", "print_section": "B", "print_page": "10", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Says No to an Amgen Bone Drug", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Says No to an Amgen Bone Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Medicine and Health", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Osteoporosis", "rank": 3, "major": "N"}, {"name": "subject", "value": "Bones", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2009-10-19T14:54:50+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d7277960-47c4-555d-9234-208704d494ab", "word_count": 639, "uri": "nyt://article/d7277960-47c4-555d-9234-208704d494ab"}